Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK-Reference-Cited by-同舟云学术

Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK

Published:2005-10 Issue:2 Volume:33 Page:135-140
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Jilma-Stohlawetz Petra,Reiter Rosemarie A.,Panzer Simon,Horvath Michaela,Eppel Wolfgang,Jilma Bernd

Publisher

Elsevier BV

Subject

Hematology

Reference24 articles.

1. Consensus conference on anti-D prophylaxis, April 7–8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists;Urbaniak;Transfusion,1998

2. Prevention of Rh haemolytic disease by immunoglobulin anti-D;Clarke;Vox Sang,1983

3. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists;Lee;Transfus Med,1999

4. Royal College of Physicians of Edinburg/Royal College of Obstetricians and Gynaecologists consensus conference on anti-D prophylaxis April 7–8 1997. Transfus Sci 2004;18:339–41.

5. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn;Kumpel;Transfus Clin Biol,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy;Frontiers in Pharmacology;2022-06-06

2. Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects;Advances in Therapy;2020-04-16

3. Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA;Lymphoma;2014-01-16

4. Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti-RhD antibody with an optimized Fc for improved engagement of FCγRIII, in healthy volunteers;Vox Sanguinis;2012-05-08

5. The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL;Blood;2012-04-05